USD 0.33
(8.36%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 3.12 Billion | 4.35 Billion | 5.68 Billion | 4.7 Billion | 6.44 Billion | 3.14 Billion |
Net Income | 2.75 Billion | 1.83 Billion | 3.32 Billion | 3.85 Billion | 3.08 Billion | 3.04 Billion |
Depreciation & Amortization | 1.67 Billion | 2.21 Billion | 2.52 Billion | 2.63 Billion | 2.5 Billion | 2.07 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -866.9 Million | 456.6 Million | 568.3 Million | -968.3 Million | 1.05 Billion | -1.26 Billion |
Other non-cash items | 30.3 Million | -158.2 Million | -733 Million | -809 Million | -203.3 Million | -702.5 Million |
Investing Cash Flow | -198.1 Million | -305.6 Million | -671.3 Million | 2.09 Billion | -4.29 Billion | -982.5 Million |
Investments in PPE | -396.9 Million | -357 Million | -716.4 Million | -643.1 Million | -711.9 Million | -917.9 Million |
Acquisitions | -2.5 Million | - | - | -500 Thousand | -21.4 Million | -94.3 Million |
Investment purchases | -45.9 Million | -571 Million | -1 Billion | -460 Million | - | -400 Million |
Sales/Maturities of investments | 20 Million | 551 Million | 1 Billion | 460 Million | - | 400 Million |
Other Investing Activities | 201.3 Million | 71.4 Million | 45.1 Million | 2.74 Billion | -3.56 Billion | 29.7 Million |
Financing Cash Flow | -3.33 Billion | -3.44 Billion | -4.49 Billion | -8.39 Billion | 275.8 Million | -1.77 Billion |
Debt repayment | -824.9 Million | -1.57 Billion | -5.15 Billion | -3.78 Billion | -1.5 Billion | -1.53 Billion |
Dividends payments | -2.23 Billion | -2.66 Billion | -1.55 Billion | -5.29 Billion | -2.6 Billion | -574.3 Million |
Common Stock Repurchased | - | - | - | - | 816.3 Million | - |
Common Stock Issuance | - | - | - | - | 7.07 Billion | - |
Other Financing Activities | 1.15 Billion | 797.3 Million | 2.2 Billion | 681.6 Million | -3.5 Billion | -1.2 Billion |
Accounts receivables | -273.5 Million | 50.5 Million | 1.08 Billion | -716.2 Million | 1.01 Billion | 81.8 Million |
Accounts payables | - | - | -1.08 Billion | 716.2 Million | -1.01 Billion | - |
Inventory | -72.7 Million | 423.1 Million | -523.6 Million | 416.6 Million | -527.8 Million | -1.4 Billion |
Other working capital | 83.1 Million | -17 Million | 11.3 Million | -668.7 Million | 571.6 Million | 138.6 Million |
Cash at beginning of period | 2.35 Billion | 1.75 Billion | 1.22 Billion | 2.82 Billion | 450.5 Million | 63.6 Million |
Cash at end of period | 1.95 Billion | 2.35 Billion | 1.75 Billion | 1.22 Billion | 2.82 Billion | 450.5 Million |
Capital Expenditure | -396.9 Million | -357 Million | -716.4 Million | -643.1 Million | -711.9 Million | -917.9 Million |
Effect of forex changes on cash | - | - | - | - | -53.4 Million | - |
Net cash flow / Change in cash | -401.4 Million | 604.8 Million | 523.8 Million | -1.59 Billion | 2.37 Billion | 386.9 Million |
Free Cash Flow | 2.73 Billion | 3.99 Billion | 4.97 Billion | 4.06 Billion | 5.73 Billion | 2.22 Billion |
Breakdown | 2024 Q4 | 2024 FY | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 121.02 Million | 2.75 Billion | 188.99 Million | 98.45 Million | 1.83 Billion | 172.87 Million |
Depreciation & Amortization | 115.83 Million | 1.67 Billion | 117.81 Million | 156.21 Million | 2.21 Billion | 168.89 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | -866.9 Million | - | - | 456.6 Million | - |
Other non-cash items | 73.29 Million | 30.3 Million | 311.35 Million | 436.28 Million | -158.2 Million | 242.18 Million |
Investing Cash Flow | -28.83 Million | -198.1 Million | -29.55 Million | -28.36 Million | -305.6 Million | -24.57 Million |
Investments in PPE | -28.37 Million | -396.9 Million | -26.43 Million | -29.25 Million | -357 Million | -21.59 Million |
Acquisitions | 156.06 Thousand | -2.5 Million | -169.6 Thousand | 723.89 Thousand | - | 45.27 Thousand |
Investment purchases | 149.35 Million | -45.9 Million | -155.44 Million | 4.84 Million | -571 Million | -86.18 Million |
Sales/Maturities of investments | -149.97 Million | 20 Million | 152.48 Million | -4.67 Million | 551 Million | 83.16 Million |
Other Investing Activities | - | 201.3 Million | -1.00 | - | 71.4 Million | - |
Financing Cash Flow | -377.36 Million | -3.33 Billion | -241.2 Million | -211.81 Million | -3.44 Billion | -233.07 Million |
Debt repayment | -14.18 Million | -824.9 Million | -99.64 Million | -145.85 Million | -1.57 Billion | -227.87 Million |
Dividends payments | -132.92 Million | -2.23 Billion | -175.3 Million | -99.05 Million | -2.66 Billion | -280.79 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -147.23 Million | 1.15 Billion | 146.99 Million | 87.29 Million | 797.3 Million | -87.29 Million |
Accounts receivables | - | -273.5 Million | - | - | 50.5 Million | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | -72.7 Million | - | - | 423.1 Million | - |
Other working capital | - | 83.1 Million | - | - | -17 Million | - |
Cash at beginning of period | 465.42 Million | 2.35 Billion | 524.87 Million | 243.12 Million | 1.75 Billion | 277.61 Million |
Cash at end of period | 289.35 Million | 1.95 Billion | 465.42 Million | 524.87 Million | 2.35 Billion | 243.12 Million |
Capital Expenditure | -28.37 Million | -396.9 Million | -26.43 Million | -29.25 Million | -357 Million | -21.59 Million |
Effect of forex changes on cash | - | - | -171.22 Million | 143.39 Million | - | -23.01 Million |
Net cash flow / Change in cash | -176.07 Million | -401.4 Million | -59.45 Million | 281.75 Million | 604.8 Million | -34.48 Million |
Free Cash Flow | 50.11 Million | 2.73 Billion | 356.1 Million | 349.27 Million | 3.99 Billion | 224.57 Million |
MAGADSUGAR
EXCELINDUS
AARTIPHARM
CTN
DKM
4265